Our report expands the phenotypic spectrum of patients with GLIS3 mutations and adds important information on the clinical course, with possible beneficial effects of pancreatic enzyme and antioxidative vitamin substitutions on characteristic NDH syndrome manifestations such as TSH resistance and cholestasis. The gene discussed is GLIS3; the disease is cholestasis.